Securities code: 000806 securities abbreviation: St Galaxy Announcement No.: 2022-003
Galaxy Biomedical Investment Co.Ltd(000806)
Announcement on the application for bankruptcy liquidation of controlling shareholders
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Galaxy Biomedical Investment Co.Ltd(000806) (hereinafter referred to as the “company”) was established in January 2022
On the 16th, we received a notice from the controlling shareholder of the company, Yinhe Tiancheng Group Co., Ltd. (hereinafter referred to as “Yinhe Group”), informing the applicant that Tiandi Heming Technology Group Co., Ltd. (hereinafter referred to as “Tiandi Heming”) applied to Nanning intermediate people’s Court of Guangxi Zhuang Autonomous Region (hereinafter referred to as “Nanning intermediate people’s court”) for breaking the Yinhe Group
Property Liquidation ([(2022) GUI 01 Po Shen No. 1]). On the same day, the company paid attention to the bankruptcy reorganization of national enterprises
Case information network disclosed that Shanghai zaixu Investment Center (limited partnership) (hereinafter referred to as “Shanghai zaixu”)
Nanjing Intermediate People’s court applied for bankruptcy liquidation of Galaxy Group ([(2022) GUI 01 Po Shen No. 2]). Company and
The relevant information is hereby announced as follows:
1、 Basic information
As of the disclosure date of this announcement, Galaxy Group has received a notice from Nanning intermediate people’s court, informing Tiandi Heming to apply to Nanning intermediate people’s court for bankruptcy liquidation of Galaxy Group on the ground that the respondent Galaxy Group is unable to pay off its due debts and obviously lacks solvency.
2、 Impact of this event on the company
The company and Galaxy Group are independent legal persons and remain independent from each other in terms of assets, personnel, business and finance. As of the date of this announcement, the daily operation and management of the company is normal.
As of the disclosure date of this announcement, Galaxy Group, as the controlling shareholder of the company, holds a total of shares of the company
261803141 shares, accounting for 23.80% of the total share capital of the company, of which 258402989 shares have been pledged,
The pledge proportion is 98.70%; 261803141 shares have been frozen, with a freezing ratio of 100%. Listed companies have
The balance formed by the illegal guarantee of galaxy group was 1646153100 yuan. Galaxy Group was insolvent, its bank account was sealed up and frozen by the court, and its realizable assets were sealed up and frozen by the court and public security.
According to the relevant provisions of the enterprise bankruptcy law of the people’s Republic of China, if Nanning intermediate people’s court accepts the bankruptcy application, the creditor’s preservation measures for the property of galaxy group shall be lifted and the execution procedure shall be suspended; The civil litigation or arbitration related to galaxy group that has begun but not ended shall be suspended; After the administrator takes over the debtor’s property, the litigation or arbitration shall continue.
The company will continue to pay attention to the follow-up progress and impact of the above matters, and timely perform the obligation of information disclosure in accordance with the relevant provisions of laws and regulations. The information disclosure media designated by the company are securities times, securities daily and http://www.cn.info.com.cn, All information of the company is subject to the information disclosed in the above designated media. Please pay attention to the relevant announcements of the company and pay attention to the investment risks.
It is hereby announced.
Galaxy Biomedical Investment Co.Ltd(000806)
Board of directors
January 17, 2002
